1. Oligonucleotides
  2. Nucleoside Analogs
  3. Thymidine

Thymidine

Thymidine (36):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-W010450
    Thymine 65-71-4 99.98%
    Thymine, one of the four bases of DNA, is a substrate for rat liver dihydropyrimidine dehydrogenase (DPD), with a Km value of 2.2 μM, Ki of 24 μM (using 5-FU as the DPD substrate), and a specific activity of 0.68 nmol/min/mg.
    Thymine
  • HY-W587829
    4-Thiothymidine 7236-57-9 99.69%
    4-Thiothymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    4-Thiothymidine
  • HY-13859
    Clevudine 163252-36-6 99.84%
    Clevudine (L-FMAU), a nucleoside analog of the unnatural L-configuration, has potent anti-HBV activity with long half-life, low toxicity. Clevudine is a non-competitive inhibitor that is not incorporated into the viral DNA but rather binds to the polymerase. Clevudine is active against cowpox virus respiratory infection in mice.
    Clevudine
  • HY-138597
    5'-O-TBDMS-dT 40733-28-6 99.43%
    5'-O-TBDMS-dT is a nucleoside with protective and modification effects.
    5'-O-TBDMS-dT
  • HY-154524
    1-(2-Deoxy-β-D-threo-pentofuranosyl)thymine 16053-52-4 99.68%
    1-(2-Deoxy-β-D-threo-pentofuranosyl)thymine is a thymidine analog. Analogs of this series have insertional activity towards replicated DNA. They can be used to label cells and track DNA synthesis.
    1-(2-Deoxy-β-D-threo-pentofuranosyl)thymine
  • HY-W357202
    7’-OH-N-trityl morpholinothymine 914361-76-5
    7’-OH-N-trityl morpholinothymine (PMO Thymidine Precusor) is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    7’-OH-N-trityl morpholinothymine
  • HY-101969
    Pseudothymidine 65358-15-8 99.44%
    Pseudothymidine is a C-nucleoside analog of thymidine.
    Pseudothymidine
  • HY-W560803
    5'-DMTr-2,2'-anhydrothymidine 817623-11-3
    5'-DMTr-2,2'-anhydrothymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    5'-DMTr-2,2'-anhydrothymidine
  • HY-154719
    5’-O-Benzoylthymidine 65475-51-6
    5’-O-Benzoylthymidine is a thymidine analog. Analogs of this series have insertional activity towards replicated DNA. They can be used to label cells and track DNA synthesis.
    5’-O-Benzoylthymidine
  • HY-154697
    3-epi-Azido-3-deoxythymidine 73971-82-1
    3-epi-Azido-3-deoxythymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    3-epi-Azido-3-deoxythymidine
  • HY-154740
    3′-Chloro-3′-deoxythymidine 25526-94-7
    3′-Chloro-3′-deoxythymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    3′-Chloro-3′-deoxythymidine
  • HY-154686
    1-(3-β-Azido-2,3-dideoxy-5-O-trityl-D-threopenta-furanosyl)thymine 66503-47-7
    1-(3-β-Azido-2,3-dideoxy-5-O-trityl-D-threopenta-furanosyl)thymine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    1-(3-β-Azido-2,3-dideoxy-5-O-trityl-D-threopenta-furanosyl)thymine
  • HY-W559353
    1-(3-Beta-amino-2,3-dideoxy-beta-d-threopenta-furanosyl)thymine 73971-79-6
    1-(3-Beta-amino-2,3-dideoxy-beta-d-threopenta-furanosyl)thymine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    1-(3-Beta-amino-2,3-dideoxy-beta-d-threopenta-furanosyl)thymine
  • HY-154554
    3’,5’-Di-O-benzoyl thymidine 35898-30-7
    3’,5’-Di-O-benzoyl thymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    3’,5’-Di-O-benzoyl thymidine
  • HY-154340
    2,3’-Anhydrothymidine 15981-92-7
    2,3’-Anhydrothymidine; 2’-Deoxy-3’,2-anhydro-5-methyluridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    2,3’-Anhydrothymidine
  • HY-154050
    3′-Chloro-3′-deoxy-5′-O-(triphenylmethyl)thymidine 34627-62-8
    3′-Chloro-3′-deoxy-5′-O-(triphenylmethyl)thymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    3′-Chloro-3′-deoxy-5′-O-(triphenylmethyl)thymidine
  • HY-154566
    5’-Deoxy-5’-N,N-diethylamino thymidine 2305415-88-5
    5’-Deoxy-5’-N,N-diethylamino thymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    5’-Deoxy-5’-N,N-diethylamino thymidine
  • HY-154347
    5'-Deoxy-5‘-iodothymidine 25953-14-4
    5′-Deoxy-5′-iodothymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    5'-Deoxy-5‘-iodothymidine
  • HY-154087
    3′-Bromo-3′-deoxythymidine 99785-51-0
    3′-Bromo-3′-deoxythymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    3′-Bromo-3′-deoxythymidine
  • HY-154348
    4’,5’-Didehydro-5’-deoxy thymidine 28034-72-2
    4’,5’-Didehydro-5’-deoxy thymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    4’,5’-Didehydro-5’-deoxy thymidine